Invest now
Q-Line Biotech share price
You have to be logged in to add this to Watchlist.- ₹523.00(-1.16%)August 18, 2026 15:27:50 PM IST
- NSE
- BSE
- Vol : 35.60 K (NSE + BSE)Last 20 day avg : 78.20 K
Q-Line Biotech is trading -1.16% lower at Rs 523.00 as compared to its last closing price. Q-Line Biotech has been trading in the price range of 534.00 & 522.00. Listed peers of Q-Line Biotech include Sun Pharmaceutical Industries (-0.32%), Divi's Laboratories (1.24%), Torrent Pharmaceuticals (1.63%).The Mutual Fund holding in Q-Line Biotech was at 1.59% in 28 May 2026. The MF holding has - from the last quarter. The FII holding in Q-Line Biotech was at 1.67% in 28 May 2026. The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 19 Aug 2026, 09:06 AM IST
- Debt To EquityHigher than industry0.88The debt-to-equity ratio, indicating a company's financial leverage.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Dividend Yield-Annual dividends as a percentage of the stock price.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Q-Line Biotech News
Q-Line Biotech Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,876.40 | -0.32 | 4,50,200.61 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,600.00 | 1.24 | 2,28,302.98 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 1.63 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,431.85 | 0.13 | 1,15,672.46 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,117.00 | -1.33 | 1,11,421.18 | 21.19 | 4.24 | 0.09 | 14.22 |
Q-Line Biotech Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-06-17 | Audited Results & Others |
About the company Q-Line Biotech
- IndustryBiotechnology & Drugs
- ISININE1G2W01011
- BSE Code
- NSE CodeQLINE
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) and consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors, who in turn sell its products to hospitals/diagnostic centers or directly to diagnostic service providers and hospitals. It has developed a diversified product portfolio in the IVD industry which includes reagents, point of care devices and kits used in clinical chemistry, coagulation, hematology, HPLC, rapid/ELISA, molecular, diagnostic instruments, equipment, consumables and services. It markets these products in around 26 states and the Union Territory with specific focus on Utter Pradesh, Rajasthan, Madhya Pradesh, Kerala and Odisha.
Q-Line Biotech Share Price FAQs
Q-Line Biotech is trading at 523.00 as on Tue Aug 18 2026 09:57:50. This is -1.16% lower as compared to its previous closing price of 529.15.
The market capitalization of Q-Line Biotech is 1220.06 Cr as on Tue Aug 18 2026 09:57:50.
The 52 wk high for Q-Line Biotech is 600.00 whereas the 52 wk low is 431.00
Q-Line Biotech can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 96.26
- Dividend Yield: %
- D/E ratio: 1.06
Q-Line Biotech reported a net profit of 56.26 Cr in 2025.
The Mutual Fund Shareholding was 1.59% at the end of 28 May 2026.
Quick Links
EQUITY QUICK LINKS
Q-Line Biotech QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.